|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/48 | (2006.01) |
| A61K 31/593 | (2006.01) | ||
| A61K 47/06 | (2006.01) | ||
| A61K 47/14 | (2006.01) | ||
| A61K 47/44 | (2006.01) |
| (11) | Number of the document | 2481400 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12154573.5 |
| Date of filing the European patent application | 2008-04-25 | |
| (97) | Date of publication of the European application | 2012-08-01 |
| (45) | Date of publication and mention of the grant of the patent | 2014-06-18 |
| (46) | Date of publication of the claims translation | 2014-11-25 |
| (30) | Number | Date | Country code |
| 913853 P | 2007-04-25 | US |
| (72) |
Bishop, Charles W., US
Tabash, Samir P., CA
Agudoawu, Sammy A., CA
White, Jay A., CA
Crawford, Keith H., US
Messner, Eric J., US
Petkovich, P. Martin, CA
|
| (73) |
Opko Renal, LLC,
4400 Biscayne Blvd., Miami, FL 33137,
US
Opko Ireland Global Holdings, Ltd., Citywest Business Campus, 3013 Lake Drive, Dublin 24, IE |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Peroralinės kontroliuojamo atpalaidavimo kompozicijos, apimančios vitamino D junginį ir vaškų nešiklį |
| Oral controlled release compositions comprising vitamin D compound and waxy carrier |
| Payment date | Validity (years) | Amount | |
| 2025-04-01 | 18 | 347.00 EUR |
| 2026-04-25 |